lauren
10-12-2004, 10:40 PM
Joe, please step in if you disagree with what I am about to say:
This study shows that WITHIN THE GROUP OF THIRTY-FIVE (35) WOMEN WHO HAD ADVANCED METASTATIC BREAST CANCER AND WHO ALSO WERE HER2NEU POSITIVE BASED ON FISH, taxotere ALONE had a better result than Adria ALONE.
THIRTY-FIVE WOMEN, GUYS. 35. ARE YOU GOING TO DRAW CONCLUSIONS BASED ON 35 WOMEN IN A 176-WOMAN STUDY? All this study tells me is that in a VERY SMALL sample of METASTATIC patients, who may or may NOT have been treated with Adria in the adjuvant setting previously, there was a benefit to receiving taxotere alone over adria alone.
Is that really a surprise in the metastatic setting? I mean, how many metastatic patients actually are given adria anyway?
People, we have to be very careful about drawing conclusions based on the studies we come across in our internet research. For a study to be useful, truly useful, it must have a LARGE population being studied, and if you are to apply the results to YOU, you need to factor in whether the setting was adjuvant or metastatic.
I am here to help, not to diss. I hate to see people freaking out thinking that adriamyicin isn't any good when their doctors gave it to them. There just isn't a sound basis for that conclusion out there. There is suggestion that taxanes may be more helpful IN A VACUUM. But if you were diagnosed today, would you say NO to adria and take a taxane alone (in the ADJUVANT setting)?
I didnt think so.
lauren
This study shows that WITHIN THE GROUP OF THIRTY-FIVE (35) WOMEN WHO HAD ADVANCED METASTATIC BREAST CANCER AND WHO ALSO WERE HER2NEU POSITIVE BASED ON FISH, taxotere ALONE had a better result than Adria ALONE.
THIRTY-FIVE WOMEN, GUYS. 35. ARE YOU GOING TO DRAW CONCLUSIONS BASED ON 35 WOMEN IN A 176-WOMAN STUDY? All this study tells me is that in a VERY SMALL sample of METASTATIC patients, who may or may NOT have been treated with Adria in the adjuvant setting previously, there was a benefit to receiving taxotere alone over adria alone.
Is that really a surprise in the metastatic setting? I mean, how many metastatic patients actually are given adria anyway?
People, we have to be very careful about drawing conclusions based on the studies we come across in our internet research. For a study to be useful, truly useful, it must have a LARGE population being studied, and if you are to apply the results to YOU, you need to factor in whether the setting was adjuvant or metastatic.
I am here to help, not to diss. I hate to see people freaking out thinking that adriamyicin isn't any good when their doctors gave it to them. There just isn't a sound basis for that conclusion out there. There is suggestion that taxanes may be more helpful IN A VACUUM. But if you were diagnosed today, would you say NO to adria and take a taxane alone (in the ADJUVANT setting)?
I didnt think so.
lauren